SCHEMBL2876152

SCHEMBL2876152

CC(CI)OC(=O)N1CCC(C(C)Oc2cnc(-c3ccc(S(C)(=O)=O)cc3)cn2)CC1

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 20/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388467 0.91 GPR119 (0.60) GPR119
SCHEMBL387669 0.91 GPR119 (0.60) GPR119
SCHEMBL385347 0.91 GPR119 (0.60) GPR119
SCHEMBL386671 0.85 GPR119 (0.57) GPR119
SCHEMBL2882005 0.82 GPR119 (0.49) GPR119
SCHEMBL4053560 0.80 GPR119 (0.52) GPR119
SCHEMBL384779 0.80 GPR119 (0.58) GPR119
SCHEMBL387399 0.78 GPR119 (0.60) GPR119
SCHEMBL388696 0.78 GPR119 (0.60) GPR119
SCHEMBL386557 0.77 GPR119 (0.64) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2010512334-A 2010-04-22 JP claimed
EP-2094683-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SmithKline Beecham Corporation (US) 2009-09-02 EP claimed
WO-2008070692-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SMITHKLINE BEECHAM CORPORATION (US) 2008-06-12 WO claimed